1 |
10365797 |
Absence of mutations in the YMDD motif/B region of the hepatitis B virus polymerase in famciclovir therapy failure. |
Mutation
|
2 |
10502255 |
Novel patterns of amino acid mutations in the hepatitis B virus polymerase in association with resistance to lamivudine therapy in japanese patients with chronic hepatitis B. |
Mutation
|
3 |
10514111 |
Diversity of core promoter mutations in immune clearance phase of chronic HBV infection. |
Mutation
|
4 |
10535488 |
Detection of pre-S/S gene mutants in chronic hepatitis B carriers with concurrent hepatitis B surface antibody and hepatitis B surface antigen. |
Mutation
|
5 |
10589947 |
Famciclovir treatment of chronic hepatitis B in heart transplant recipients: a prospective trial. |
Mutation
|
6 |
10607231 |
Hepatitis B envelope protein mutants in human hepatocellular carcinoma tissues. |
Mutation
|
7 |
10655370 |
Line probe assay for monitoring drug resistance in hepatitis B virus-infected patients during antiviral therapy. |
Mutation
|
8 |
10762559 |
Evolution of hepatitis B virus polymerase gene sequence during famciclovir therapy for chronic hepatitis B. |
Mutation
|
9 |
10996115 |
In vivo dynamics and pathogenicity of wild-type and resistant Hepatitis B virus during long-term lamivudine monotherapy - a clinical note. |
Mutation
|
10 |
11002246 |
Hepatitis B virus X gene variability in French-born patients with chronic hepatitis and hepatocellular carcinoma. |
Mutation
|
11 |
11020004 |
Genotypic succession of mutations of the hepatitis B virus polymerase associated with lamivudine resistance. |
Mutation
|
12 |
11050059 |
Early detection of viral resistance by determination of hepatitis B virus polymerase mutations in patients treated by lamivudine for chronic hepatitis B. |
Mutation
|
13 |
11124839 |
A case-control study for clinical and molecular biological differences between hepatitis B viruses of genotypes B and C. Japan HBV Genotype Research Group. |
Mutation
|
14 |
11472634 |
Low frequency of mutations in the core promoter and precore regions of hepatitis B virus in anti-HBe positive Brazilian carriers. |
Mutation
|
15 |
11480792 |
Efficacy and tolerability of long-term therapy using high lamivudine doses for the treatment of chronic hepatitis B. |
Mutation
|
16 |
11502520 |
In vitro susceptibilities of wild-type or drug-resistant hepatitis B virus to (-)-beta-D-2,6-diaminopurine dioxolane and 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil. |
Mutation
|
17 |
11584376 |
Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy. |
Mutation
|
18 |
11792996 |
Efficacy of famciclovir in the treatment of lamivudine resistance related to an atypical hepatitis B virus mutant. |
Mutation
|
19 |
11907436 |
Seroconversion after the addition of famciclovir therapy in a child with hepatitis B virus infection after liver transplantation who developed lamivudine resistance. |
Mutation
|
20 |
11938042 |
Lamivudine therapy of chronic hepatitis B in three groups of patients: non transplanted patients, liver recipients, and kidney recipients. |
Mutation
|
21 |
11993512 |
Hepatitis B genotypes and precore/basal core promoter mutants in HBeAg-negative chronic hepatitis B. |
Mutation
|
22 |
12010505 |
Sequential analysis of hepatitis B virus core promoter and precore regions in cancer survivor patients with chronic hepatitis B before, during and after interferon treatment. |
Mutation
|
23 |
12033768 |
In vivo suppression of precore mRNA synthesis is associated with mutations in the hepatitis B virus core promoter. |
Mutation
|
24 |
12135788 |
'Hbe minus' mutants of hepatitis B virus. Molecular characterization and its relation to viral genotypes. |
Mutation
|
25 |
12358268 |
Core promoter mutations 3 years after anti-hepatitis B e seroconversion in patients with chronic hepatitis B or hepatitis B and C infection and cancer remission. |
Mutation
|
26 |
12368144 |
[Evaluation of a quantitative HBV-DNA PCR assay in lamivudine treated hepatitis B-infected patients]. |
Mutation
|
27 |
12436473 |
Hepatitis B virus S gene mutants in a patient with chronic active hepatitis with circulating Anti-HBs antibodies. |
Mutation
|
28 |
12445424 |
Mutations of polymerase, precore and core promoter gene in hepatitis B virus during 5-year lamivudine therapy. |
Mutation
|
29 |
12657823 |
[Natural YMDD motif mutations of HBV polymerase in the chronic hepatitis B virus infected patients]. |
Mutation
|
30 |
12727536 |
Lamivudine and Famciclovir resistant hepatitis B virus associated with fatal hepatic failure. |
Mutation
|
31 |
12759956 |
[Dynamic changes of basal core promoter and pre-core mutants of hepatitis B virus in patients with chronic hepatitis B virus infection]. |
Mutation
|
32 |
12794713 |
Molecular epidemiology and transmission of hepatitis B virus in close family contacts of HBV-related chronic liver disease patients. |
Mutation
|
33 |
12823594 |
Analysis of clinical, biochemical and viral factors associated with early relapse after lamivudine treatment for hepatitis B e antigen-negative chronic hepatitis B patients in Taiwan. |
Mutation
|
34 |
12829991 |
Week 48 resistance surveillance in two phase 3 clinical studies of adefovir dipivoxil for chronic hepatitis B. |
Mutation
|
35 |
12891527 |
Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase. |
Mutation
|
36 |
12918112 |
Novel assay of competitively differentiated polymerase chain reaction for screening point mutation of hepatitis B virus. |
Mutation
|
37 |
12931030 |
Low HBeAg serum levels correlate with the presence of the double A1762T/G1764A core promoter mutation and a positive response to interferon in patients with chronic hepatitis B virus infection. |
Mutation
|
38 |
12966541 |
Evolution of hepatitis B virus sequence from a liver transplant recipient with rapid breakthrough despite hepatitis B immune globulin prophylaxis and lamivudine therapy. |
Mutation
|
39 |
12974898 |
Identification of a novel pre-S2 mutation in a subgroup of chronic carriers with spontaneous clearance of hepatitis B virus surface antigen. |
Mutation
|
40 |
14654974 |
Early response to interferon alpha treatment and long-term clinical outcome in Japanese patients with chronic HBV genotype C infection. |
Mutation
|
41 |
14675262 |
Evolution of wild type and mutants of the YMDD motif of hepatitis B virus polymerase during lamivudine therapy. |
Mutation
|
42 |
14752824 |
Identification of HBV DNA sequences that are predictive of response to lamivudine therapy. |
Mutation
|
43 |
14756274 |
Efficacy of combined lamivudine and adefovir dipivoxil treatment for severe HBV graft reinfection after living donor liver transplantation. |
Mutation
|
44 |
15078472 |
Sequential combination therapy of HBe antigen-negative/virus-DNA-positive chronic hepatitis B with famciclovir or lamivudine and interferon-alpha-2a. |
Mutation
|
45 |
15240859 |
Longitudinal study on mutation profiles of core promoter and precore regions of the hepatitis B virus genome in children. |
Mutation
|
46 |
15308845 |
Detection of YMDD motif mutants by oligonucleotide chips in lamivudine-untreated patients with chronic hepatitis B virus infection. |
Mutation
|
47 |
15311721 |
Efficacy of alpha interferon therapy for lamivudine resistance in chronic hepatitis B. |
Mutation
|
48 |
15328117 |
Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to Lamivudine. |
Mutation
|
49 |
15338371 |
Prognostic indicators of breakthrough hepatitis during lamivudine monotherapy for chronic hepatitis B virus infection. |
Mutation
|
50 |
15340520 |
[A study on detection method of lamivudine related mutations in hepatitis B virus polymerase gene]. |
Mutation
|
51 |
15544736 |
[Determination of hepatitis B virus genotype and detection of lamivudine-resistance mutations]. |
Mutation
|
52 |
15572007 |
The precore mutation is associated with severity of liver damage in Brazilian patients with chronic hepatitis B. |
Mutation
|
53 |
15618847 |
Long-term therapy with lamivudine in renal transplant recipients with chronic hepatitis B. |
Mutation
|
54 |
15634980 |
Development of a molecular-beacon assay to detect the G1896A precore mutation in hepatitis B virus-infected individuals. |
Mutation
|
55 |
15648063 |
Clinical and virological characteristics of lamivudine resistance in chronic hepatitis B patients: a single center experience. |
Mutation
|
56 |
15655050 |
Activity of adefovir dipivoxil against all patterns of lamivudine-resistant hepatitis B viruses in patients. |
Mutation
|
57 |
15664258 |
Sustained HBs seroconversion during lamivudine and adefovir dipivoxil combination therapy for lamivudine failure. |
Mutation
|
58 |
15720530 |
Long-term follow-up of chronic hepatitis B after the emergence of mutations in the hepatitis B virus polymerase region. |
Mutation
|
59 |
15720534 |
Three-phase sequential combined treatment with lamivudine and interferon in young patients with chronic hepatitis B. |
Mutation
|
60 |
15834874 |
Nucleotide mutations associated with hepatitis B e antigen negativity. |
Mutation
|
61 |
15893561 |
A novel accurate amplification created restriction site method for determination of the wild type and the precore mutant hepatitis B virus variants. |
Mutation
|
62 |
15932365 |
Changes in different regions of hepatitis B virus gene in hepatitis B 'e' antigen-negative patients with chronic hepatitis B: the effect of long-term lamivudine therapy. |
Mutation
|
63 |
15953865 |
Overlapping gene mutations of hepatitis B virus in a chronic hepatitis B patient with hepatitis B surface antigen loss during lamivudine therapy. |
Mutation
|
64 |
15973769 |
Character of HBV (hepatitis B virus) polymerase gene rtM204V/I and rtL180M mutation in patients with lamivudine resistance. |
Mutation
|
65 |
15980328 |
Emergence of a novel mutation in the FLLA region of hepatitis B virus during lamivudine therapy. |
Mutation
|
66 |
15985011 |
Response to long-term lamivudine treatment (up to 5 years) in patients with severe chronic hepatitis B, role of genotype and drug resistance. |
Mutation
|
67 |
16080797 |
HBx M130K and V131I (T-A) mutations in HBV genotype F during a follow-up study in chronic carriers. |
Mutation
|
68 |
16099903 |
T1764G1766 core promoter double mutants are restricted to Hepatitis B virus strains with an A1757 and are common in genotype D. |
Mutation
|
69 |
16108169 |
Chronic hepatitis B--treatment with nucleoside analogues. |
Mutation
|
70 |
16197491 |
Clinical reactivation during lamivudine treatment correlates with mutations in the precore/core promoter and polymerase regions of hepatitis B virus in patients with anti-hepatitis B e-positive chronic hepatitis. |
Mutation
|
71 |
16220028 |
Hepatitis B virus DNA quantitation and detection of core promoter, precore and polymerase mutations in chronic hepatitis B: evaluation and clinical usefulness of three new commercial assays. |
Mutation
|
72 |
16227269 |
Reduced secretion of virions and hepatitis B virus (HBV) surface antigen of a naturally occurring HBV variant correlates with the accumulation of the small S envelope protein in the endoplasmic reticulum and Golgi apparatus. |
Mutation
|
73 |
16358376 |
Clinical features of chronic hepatitis B patients with YMDD mutation after lamivudine therapy. |
Mutation
|
74 |
16428891 |
Characterization of naturally occurring and Lamivudine-induced surface gene mutants of hepatitis B virus in patients with chronic hepatitis B in India. |
Mutation
|
75 |
16448607 |
[Lamivudine and adefovir resistance in a patient with HBeAg negative chronic hepatitis B]. |
Mutation
|
76 |
16461777 |
Resistance to adefovir dipivoxil in lamivudine resistant chronic hepatitis B patients treated with adefovir dipivoxil. |
Mutation
|
77 |
16517839 |
Phylogenetic, virological, and clinical characteristics of genotype C hepatitis B virus with TCC at codon 15 of the precore region. |
Mutation
|
78 |
16618409 |
Predominance of hepatitis B virus YMDD mutants is prognostic of viral DNA breakthrough. |
Mutation
|
79 |
16618410 |
High prevalence and mapping of pre-S deletion in hepatitis B virus carriers with progressive liver diseases. |
Mutation
|
80 |
16637865 |
Association of core promoter/precore mutations and viral load in e antigen-negative chronic hepatitis B patients. |
Mutation
|
81 |
16637866 |
Hepatitis B virus genotypes and G1896A precore mutation in 486 Spanish patients with acute and chronic HBV infection. |
Mutation
|
82 |
16729316 |
Increased risk of adefovir resistance in patients with lamivudine-resistant chronic hepatitis B after 48 weeks of adefovir dipivoxil monotherapy. |
Mutation
|
83 |
16757589 |
Detection of rtN236T and rtA181V/T mutations associated with resistance to adefovir dipivoxil in samples from patients with chronic hepatitis B virus infection by the INNO-LiPA HBV DR line probe assay (version 2). |
Mutation
|
84 |
16757620 |
Unusual naturally occurring humoral and cellular mutated epitopes of hepatitis B virus in a chronically infected argentine patient with anti-HBs antibodies. |
Mutation
|
85 |
16789011 |
Changes in viral loads of lamivudine-resistant mutants and evolution of HBV sequences during adefovir dipivoxil therapy. |
Mutation
|
86 |
16789012 |
Basal core promoter, precore region mutations of HBV and their association with e antigen, genotype, and severity of liver disease in patients with chronic hepatitis B in India. |
Mutation
|
87 |
16830379 |
Mutations in surface and polymerase gene of chronic hepatitis B patients with coexisting HBsAg and anti-HBs. |
Mutation
|
88 |
16847965 |
Identification of hepatitis B virus subgenotype A3 in rural Gabon. |
Mutation
|
89 |
16856618 |
The clinical impact of early detection of the YMDD mutant on the outcomes of long-term lamivudine therapy in patients with chronic hepatitis B. |
Mutation
|
90 |
16871563 |
Tenofovir for patients with lamivudine-resistant hepatitis B virus (HBV) infection and high HBV DNA level during adefovir therapy. |
Mutation
|
91 |
16928212 |
Association of core promoter mutations with viral breakthrough in chronic hepatitis B patients on long-term lamivudine therapy. |
Mutation
|
92 |
16963200 |
A unique amino acid substitution, T126I, in human genotype C of hepatitis B virus S gene and its possible influence on antigenic structural change. |
Mutation
|
93 |
16982790 |
Emergence of a novel lamivudine-resistant hepatitis B virus variant with a substitution outside the YMDD motif. |
Mutation
|
94 |
17030194 |
Selection of a multiple drug-resistant hepatitis B virus strain in a liver-transplanted patient. |
Mutation
|
95 |
17178796 |
Two-year assessment of entecavir resistance in Lamivudine-refractory hepatitis B virus patients reveals different clinical outcomes depending on the resistance substitutions present. |
Mutation
|
96 |
17187404 |
Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein. |
Mutation
|
97 |
17203204 |
Genotype and variations in core promoter and pre-core regions are related to progression of disease in HBV-infected patients from Northern Vietnam. |
Mutation
|
98 |
17239478 |
Stepwise process for the development of entecavir resistance in a chronic hepatitis B virus infected patient. |
Mutation
|
99 |
17258721 |
Identification of a hepatitis B virus S gene mutant in lamivudine-treated patients experiencing HBsAg seroclearance. |
Mutation
|
100 |
17259736 |
G1862T mutation among hepatitis B virus-infected individuals: association with viral genotypes and disease outcome in Kolkata, Eastern India. |
Mutation
|
101 |
17302381 |
Unusual selection of rtA181V HBV mutants cross-resistant to adefovir following prolonged lamivudine monotherapy: report of two cases. |
Mutation
|
102 |
17317127 |
Dynamic changes of hepatitis B virus polymerase gene including YMDD motif in lamivudine-treated patients with chronic hepatitis B. |
Mutation
|
103 |
17400303 |
Adefovir dipivoxil treatment of lamivudine-resistant chronic hepatitis B. |
Mutation
|
104 |
17498248 |
Analysis of the core gene of hepatitis B virus in Korean patients. |
Mutation
|
105 |
17627632 |
Impact of viral genotypes and naturally occurring mutations on biological properties of hepatitis B virus. |
Mutation
|
106 |
17652045 |
Sequential treatment with lamivudine and alpha-interferon in anti-HBe-positive chronic hepatitis B patients: a pilot study. |
Mutation
|
107 |
17682718 |
[A case of chronic hepatitis B with primary adefovir resistance]. |
Mutation
|
108 |
17692425 |
Pooled analysis of amino acid changes in the HBV polymerase in patients from four major adefovir dipivoxil clinical trials. |
Mutation
|
109 |
17697019 |
Association between lamivudine sensitivity and the number of substitutions in the reverse transcriptase region of the hepatitis B virus polymerase. |
Mutation
|
110 |
17713159 |
A novel mutation pattern emerging during lamivudine treatment shows cross-resistance to adefovir dipivoxil treatment. |
Mutation
|
111 |
17825452 |
Five subgenotypes of hepatitis B virus genotype B with distinct geographic and virological characteristics. |
Mutation
|
112 |
17854034 |
Mutational patterns of hepatitis B virus genome and clinical outcomes after emergence of drug-resistant variants during lamivudine therapy: analyses of the polymerase gene and full-length sequences. |
Mutation
|
113 |
17888035 |
Analysis of the complete hepatitis B virus genome in patients with genotype C chronic hepatitis and hepatocellular carcinoma. |
Mutation
|
114 |
17900990 |
The high prevalence of the I27 mutant HBcAg18-27 epitope in Chinese HBV-infected patients and its cross-reactivity with the V27 prototype epitope. |
Mutation
|
115 |
17913933 |
Evolution of primary and compensatory lamivudine resistance mutations in chronic hepatitis B virus-infected patients during long-term lamivudine treatment, assessed by a line probe assay. |
Mutation
|
116 |
17934636 |
Hepatitis B virus genotype E detected in Brazil in an African patient who is a frequent traveler. |
Mutation
|
117 |
17971947 |
[Efficacy of adefovir dipivoxil was not related to genotypes B and C of hepatitis B virus: a randomized, double-blind, multicenter clinical study]. |
Mutation
|
118 |
17988612 |
[Adefovir dipivoxil compassionate use program in Spain: efficacy and resistance analysis]. |
Mutation
|
119 |
18036104 |
Efficacy of hepatitis B virus (HBV) vaccination in treating lamivudine-resistant HBV reactivation following hepatitis B surface antigen seroconversion. |
Mutation
|
120 |
18036224 |
Hepatitis B virus genotypes circulating in Brazil: molecular characterization of genotype F isolates. |
Mutation
|
121 |
18070286 |
Hepatitis B virus polymerase variants associated with entecavir drug resistance in treatment-naive patients. |
Mutation
|
122 |
18159582 |
Lamivudine therapy for korean children with chronic hepatitis B. |
Mutation
|
123 |
18171343 |
Lamivudine resistance and other mutations in the polymerase and surface antigen genes of hepatitis B virus associated with a fatal hepatic failure case. |
Mutation
|
124 |
18211717 |
Hepatitis B virus genotypes and resistance mutations in patients under long term lamivudine therapy: characterization of genotype G in Brazil. |
Mutation
|
125 |
18265656 |
Clinical significance of basal core promoter and precore mutations in chronic hepatitis B. |
Mutation
|
126 |
18266648 |
A complete genomic analysis of hepatitis B virus genotypes and mutations in HBeAg-negative chronic hepatitis B in China. |
Mutation
|
127 |
18329126 |
Lamivudine compared with lamivudine and adefovir dipivoxil for the treatment of HBeAg-positive chronic hepatitis B. |
Mutation
|
128 |
18433023 |
Safety, efficacy, and pharmacokinetics of adefovir dipivoxil in children and adolescents (age 2 to <18 years) with chronic hepatitis B. |
Mutation
|
129 |
18433925 |
Low risk of adefovir resistance in lamivudine-resistant chronic hepatitis B patients treated with adefovir plus lamivudine combination therapy: two-year follow-up. |
Mutation
|
130 |
18504191 |
[Mutations of HBV polymerase gene sequence in lamivudine-resistant chronic hepatitis B patients]. |
Mutation
|
131 |
18507754 |
Clinical significance of precore and core promoter mutations in genotype D hepatitis B-related chronic liver disease. |
Mutation
|
132 |
18537180 |
The antiviral drug selected hepatitis B virus rtA181T/sW172* mutant has a dominant negative secretion defect and alters the typical profile of viral rebound. |
Mutation
|
133 |
18551606 |
Hepatitis B virus X mutations occurring naturally associated with clinical severity of liver disease among Korean patients with chronic genotype C infection. |
Mutation
|
134 |
18571815 |
Defective hepatitis B virus DNA is not associated with disease status but is reduced by polymerase mutations associated with drug resistance. |
Mutation
|
135 |
18605187 |
[HBV gene variants and polymerse gene mutations in children with chronic hepatitis B in the course of the antiviral therapy]. |
Mutation
|
136 |
18606836 |
Rolling circle amplification, a powerful tool for genetic and functional studies of complete hepatitis B virus genomes from low-level infections and for directly probing covalently closed circular DNA. |
Mutation
|
137 |
18647234 |
Expression of hepatitis B virus nuclear core antigen in young cirrhotic patients is associated with an unfavourable long-term outcome. |
Mutation
|
138 |
18752330 |
Long-term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B. |
Mutation
|
139 |
18814242 |
Clinical significance of a set of single nucleotide polymorphisms of hepatitis B virus core gene in Chinese Han patients with chronic hepatitis B. |
Mutation
|
140 |
18822888 |
[YMDD motif variants detected by Inno-Lipa HBV DR assay in chronic hepatitis B patients during lamivudine therapy]. |
Mutation
|
141 |
19065672 |
Complex dynamics of hepatitis B virus resistance to adefovir. |
Mutation
|
142 |
19070921 |
The association of HBV core promoter double mutations (A1762T and G1764A) with viral load differs between HBeAg positive and anti-HBe positive individuals: a longitudinal analysis. |
Mutation
|
143 |
19107976 |
Lamivudine monoprophylaxis and adefovir salvage for liver transplantation in chronic hepatitis B: a seven-year follow-up study. |
Mutation
|
144 |
19119245 |
[The efficacy of adefovir dipivoxil monotherapy and the incidence of genotypic resistance to adefovir dipivoxil in patients with lamivudine-resistant chronic hepatitis B infection]. |
Mutation
|
145 |
19125938 |
Spontaneous HBeAg seroconversion and loss of hepatitis B virus DNA after acute flare due to development of drug resistant mutants during entecavir monotherapy. |
Mutation
|
146 |
19152408 |
Susceptibility of hepatitis B virus to lamivudine restored by resistance to adefovir. |
Mutation
|
147 |
19152409 |
Association of lamivudine-resistant mutational patterns with the antiviral effect of adefovir in patients with chronic hepatitis B. |
Mutation
|
148 |
19195324 |
Adefovir for chronic hepatitis B treatment: identification of virological markers linked to therapy response. |
Mutation
|
149 |
19207682 |
Hepatitis B virus genotypes and hepatitis B surface antigen mutations in family contacts of hepatitis B virus infected patients with occult hepatitis B virus infection. |
Mutation
|
150 |
19222103 |
Hepatitis B virus mutations potentially conferring adefovir/tenofovir resistance in treatment-naive patients. |
Mutation
|
151 |
19231002 |
Entecavir shows limited efficacy in HBeAg-positive hepatitis B patients with a partial virologic response to adefovir therapy. |
Mutation
|
152 |
19280622 |
Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy. |
Mutation
|
153 |
19301976 |
Ultra-deep pyrosequencing of hepatitis B virus quasispecies from nucleoside and nucleotide reverse-transcriptase inhibitor (NRTI)-treated patients and NRTI-naive patients. |
Mutation
|
154 |
19302908 |
Evolution of hepatitis B virus polymerase mutations in a patient with HBeAg-positive chronic hepatitis B virus treated with sequential monotherapy and add-on nucleoside/nucleotide analogues. |
Mutation
|
155 |
19319958 |
Prevalence of basal core promoter and precore mutations in Chinese chronic hepatitis B patients and correlation with serum HBeAG titers. |
Mutation
|
156 |
19323782 |
Hepatitis B virus with the rtL80V/I mutation is associated with a poor response to adefovir dipivoxil therapy. |
Mutation
|
157 |
19382250 |
Frequent detection of hepatitis B virus variants associated with lamivudine resistance in treated South African patients infected chronically with different HBV genotypes. |
Mutation
|
158 |
19430095 |
Association of baseline viral factors with response to lamivudine therapy in chronic hepatitis B patients with high serum alanine aminotransferase levels. |
Mutation
|
159 |
19442845 |
A sensitive direct sequencing assay based on nested PCR for the detection of HBV polymerase and surface glycoprotein mutations. |
Mutation
|
160 |
19486254 |
Characterization of hepatitis B virus reverse transcriptase sequences in Chinese treatment naive patients. |
Mutation
|
161 |
19489434 |
[Analysis of the relevance of the mutations of the precore and basic core promoter in HBV genome with the DNA amount of HBV viremia]. |
Mutation
|
162 |
19550344 |
Monitoring of therapy in patients with chronic hepatitis B virus. |
Mutation
|
163 |
19566788 |
Naturally occurring amino-acid substitutions to nucleos(t)ide analogues in treatment naive Turkish patients with chronic hepatitis B. |
Mutation
|
164 |
19578241 |
Adefovir dipivoxil resistance patterns in patients with lamivudine-resistant chronic hepatitis B. |
Mutation
|
165 |
19578244 |
Clinical and virological responses to clevudine therapy in chronic hepatitis B patients: results at 1 year of an open-labelled prospective study. |
Mutation
|
166 |
19581770 |
[Long-term clevudine therapy in nucleos(t)ide-naïve and lamivudine-experienced patients with hepatitis B virus-related chronic liver diseases]. |
Mutation
|
167 |
19651117 |
Detection of the rtA181V/T and rtN236T mutations associated with resistance to adefovir dipivoxil using a ligase detection reaction assay. |
Mutation
|
168 |
19785624 |
Prevalence of hepatitis B virus DNA polymerase mutations in treatment-naïve patients with chronic hepatitis B. |
Mutation
|
169 |
19795617 |
[Entecavir resistance in entecavir naive lamivudine treated chronic hepatitis B patients]. |
Mutation
|
170 |
19800842 |
Hepatitis B precore/core promoter mutations in isolates from HBV-monoinfected and HBV-HIV coinfected patients: a 3-yr prospective study. |
Mutation
|
171 |
19811086 |
Downregulation of HLA class II molecules by G1896A pre-core mutation in chronic hepatitis B virus infection. |
Mutation
|
172 |
19817965 |
Occult hepatitis B virus infection and lamivudine-resistant mutations in isolates from renal patients undergoing hemodialysis. |
Mutation
|
173 |
19933798 |
Mechanism of entecavir resistance of hepatitis B virus with viral breakthrough as determined by long-term clinical assessment and molecular docking simulation. |
Mutation
|
174 |
19950231 |
PreS deletion mutations of hepatitis B virus in chronically infected patients with simultaneous seropositivity for hepatitis-B surface antigen and anti-HBS antibodies. |
Mutation
|
175 |
20007398 |
Selection and counterselection of the rtI233V adefovir resistance mutation during antiviral therapy. |
Mutation
|
176 |
20034521 |
Characterization of potential antiviral resistance mutations in hepatitis B virus reverse transcriptase sequences in treatment-naïve Chinese patients. |
Mutation
|
177 |
20077675 |
[Analysis on mutation of S gene and P gene of hepatitis B virus in two counties of Sichuan Province]. |
Mutation
|
178 |
20087936 |
Molecular evolutionary analysis and mutational pattern of full-length genomes of hepatitis B virus isolated from Belgian patients with different clinical manifestations. |
Mutation
|
179 |
20119580 |
Hepatitis B viral surface mutations in patients with adefovir resistant chronic hepatitis B with A181T/V polymerase mutations. |
Mutation
|
180 |
20164224 |
Identification and characterization of clevudine-resistant mutants of hepatitis B virus isolated from chronic hepatitis B patients. |
Mutation
|
181 |
20173647 |
T1653 mutation in the enhancer II region of the hepatitis B virus genome in southern African Blacks with hepatocellular carcinoma. |
Mutation
|
182 |
20184927 |
Molecular characteristics and functional analysis of full-length hepatitis B virus quasispecies from a patient with chronic hepatitis B virus infection. |
Mutation
|
183 |
20222172 |
Establishment of a new quantitative detection approach to adefovir-resistant HBV and its clinical application. |
Mutation
|
184 |
20332649 |
Response to adefovir depends on mutation patterns in precore region, basal core promoter and reverse transcriptase, and on-treatment responses in Lamivudine-resistant chronic hepatitis B patients. |
Mutation
|
185 |
20382061 |
Monitoring of hepatitis B virus surface antigen escape mutations and concomitantly nucleos(t)ide analog resistance mutations in Turkish patients with chronic hepatitis B. |
Mutation
|
186 |
20586936 |
rtE218G, a novel hepatitis B virus mutation with resistance to adefovir dipivoxil in patients with chronic hepatitis B. |
Mutation
|
187 |
20848146 |
Association of hepatitis B virus mutations in basal core promoter and precore regions with severity of liver disease: an investigation of 793 Chinese patients with mild and severe chronic hepatitis B and acute-on-chronic liver failure. |
Mutation
|
188 |
20959817 |
Association between the various mutations in viral core promoter region to different stages of hepatitis B, ranging of asymptomatic carrier state to hepatocellular carcinoma. |
Mutation
|
189 |
20970466 |
Characterization of hepatitis virus B isolated from a multi-drug refractory patient. |
Mutation
|
190 |
21056552 |
Variable influence of mutational patterns in reverse-transcriptase domain on replication capacity of hepatitis B virus isolates from antiviral-experienced patients. |
Mutation
|
191 |
21149924 |
Profile of HBV antiviral resistance mutations with distinct evolutionary pathways against nucleoside/nucleotide analogue treatment among Chinese chronic hepatitis B patients. |
Mutation
|
192 |
21168854 |
Human interleukin-10 genotypes are associated with different precore/core gene mutation patterns in children with chronic hepatitis B virus infection. |
Mutation
|
193 |
21177673 |
Detection of hepatitis B virus genotype A3 and primary drug resistance mutations in African immigrants with chronic hepatitis B in Spain. |
Mutation
|
194 |
21181915 |
Presence of valine at position 27 of the hepatitis B virus core gene is associated with severe liver inflammation in Chinese patients. |
Mutation
|
195 |
21181918 |
Molecular epidemiology of chronic hepatitis B virus infection in Greece. |
Mutation
|
196 |
21264860 |
Gender disparity in distribution of the major hydrophilic region variants of hepatitis B virus genotype C according to hepatitis B e antigen serostatus. |
Mutation
|
197 |
21311107 |
HBV core region variability: effect of antiviral treatments on main epitopic regions. |
Mutation
|
198 |
21323729 |
Natural history of chronic hepatitis B REVEALed. |
Mutation
|
199 |
21392168 |
Genotypic resistance profile of hepatitis B virus (HBV) in a large cohort of nucleos(t)ide analogue-experienced Chinese patients with chronic HBV infection. |
Mutation
|
200 |
21396961 |
HBV DNA replication mediated by cloned patient HBV reverse transcriptase genes from HBV genotypes A-H and its use in antiviral phenotyping assays. |
Mutation
|
201 |
21442057 |
Predictors for early HBeAg loss during lamivudine therapy in HBeAg-positive chronic hepatitis B patients with acute exacerbation. |
Mutation
|
202 |
21461076 |
Association between Hepatitis B Virus X Gene Mutations and Clinical Status in Patients with Chronic Hepatitis B Infection. |
Mutation
|
203 |
21468263 |
Precore and core promoter mutations of the hepatitis B virus gene in chronic genotype C-infected children. |
Mutation
|
204 |
21484144 |
A comparison of 48-week treatment efficacy between clevudine and entecavir in treatment-naïve patients with chronic hepatitis B. |
Mutation
|
205 |
21484148 |
Extended treatment with lamivudine and adefovir dipivoxil in chronic hepatitis B patients with lamivudine resistance. |
Mutation
|
206 |
21490166 |
Impact of hepatitis B virus (HBV) x gene mutations on hepatocellular carcinoma development in chronic HBV infection. |
Mutation
|
207 |
21503906 |
Clinical course and predictive factors of virological response in long-term lamivudine plus adefovir dipivoxil combination therapy for lamivudine-resistant chronic hepatitis B patients. |
Mutation
|
208 |
21503942 |
Emergence of hepatitis B virus S gene mutants in patients experiencing hepatitis B surface antigen seroconversion after peginterferon therapy. |
Mutation
|
209 |
21569538 |
A336C/A336T/T337C variations in HBV core gene and spontaneous hepatitis B e antigen loss in chronic hepatitis B patients. |
Mutation
|
210 |
21601012 |
Molecular characterization and phylogenetic analysis of full-genome HBV subgenotype D3 sequences from Serbia. |
Mutation
|
211 |
21640384 |
Hepatitis B genotypes/subgenotypes and MHR variants among Moroccan chronic carriers. |
Mutation
|
212 |
21665530 |
Quantification of complex precore mutations of hepatitis B virus by SimpleProbe real time PCR and dual melting analysis. |
Mutation
|
213 |
21692935 |
Large-scale survey of naturally occurring HBV polymerase mutations associated with anti-HBV drug resistance in untreated patients with chronic hepatitis B. |
Mutation
|
214 |
21734806 |
Long-term effects of lamivudine treatment in Japanese chronic hepatitis B patients. |
Mutation
|
215 |
21742757 |
Ultra-deep pyrosequencing analysis of the hepatitis B virus preCore region and main catalytic motif of the viral polymerase in the same viral genome. |
Mutation
|
216 |
21784687 |
Antiviral drug-associated potential vaccine-escape hepatitis B virus mutants in Turkish patients with chronic hepatitis B. |
Mutation
|
217 |
21785721 |
Evolution of Hepatitis B Virus in a Chronic HBV-Infected Patient over 2 Years. |
Mutation
|
218 |
21789847 |
[Variants and quasispecies of reverse transcriptase region in polymerase gene of hepatitis B virus during lamivudine treatment]. |
Mutation
|
219 |
21814558 |
The G1613A mutation in the HBV genome affects HBeAg expression and viral replication through altered core promoter activity. |
Mutation
|
220 |
21816062 |
Lamivudine plus adefovir is a good option for chronic hepatitis B patients with viral relapse after cessation of lamivudine treatment. |
Mutation
|
221 |
21863638 |
[One-year combination therapy de novo of adefovir dipivoxil and lamivudine for decompensated cirrhosis related to HBV]. |
Mutation
|
222 |
21883736 |
Four-year follow-up of two chronic hepatitis B recipients of hepatitis B surface antigen-positive cadaveric liver grafts from asymptomatic carriers. |
Mutation
|
223 |
21911882 |
Evolution of hepatitis B virus during long-term therapy in patients with chronic hepatitis B. |
Mutation
|
224 |
21933446 |
Emergence of the rtA181T/sW172* mutant increased the risk of hepatoma occurrence in patients with lamivudine-resistant chronic hepatitis B. |
Mutation
|
225 |
21959623 |
Molecular epidemical characteristics of Lamivudine resistance mutations of HBV in southern China. |
Mutation
|
226 |
22007495 |
[Effect of Lamivudine on chronic hepatitis B patients with chemotherapy or immunosuppressive agents therapy and research the drug resistance]. |
Mutation
|
227 |
22052677 |
Phenotypic assay of a hepatitis B virus strain carrying an rtS246T variant using a new strategy. |
Mutation
|
228 |
22087110 |
A study of genotypes, mutants and nucleotide sequence of hepatitis B virus in Pakistan: HBV genotypes in pakistan. |
Mutation
|
229 |
22097972 |
Five years of treatment with adefovir dipivoxil in Chinese patients with HBeAg-positive chronic hepatitis B. |
Mutation
|
230 |
22098177 |
The influence of YMDD mutation patterns on clinical outcomes in patients with adefovir add-on lamivudine combination treatment. |
Mutation
|
231 |
22138714 |
Prevalence, virology and antiviral drugs susceptibility of hepatitis B virus rtN238H polymerase mutation from 1865 Chinese patients with chronic hepatitis B. |
Mutation
|
232 |
22170539 |
Discrepancy of potential antiviral resistance mutation profiles within the HBV reverse transcriptase between nucleos(t)ide analogue-untreated and -treated patients with chronic hepatitis B in a hospital in China. |
Mutation
|
233 |
22170540 |
Pre-existing YMDD mutants in treatment-naïve patients with chronic hepatitis B are not selected during lamivudine therapy. |
Mutation
|
234 |
22173170 |
Quantitative dynamics of hepatitis B basal core promoter and precore mutants before and after HBeAg seroconversion. |
Mutation
|
235 |
22233650 |
Hepatitis B surface gene 145 mutant as a minor population in hepatitis B virus carriers. |
Mutation
|
236 |
22246826 |
Characterization of hepatitis B virus genome variability in Iranian patients with chronic infection, a nationwide study. |
Mutation
|
237 |
22260834 |
Risk factors of gene-resistant mutations in different nucleosides. |
Mutation
|
238 |
22312387 |
Multidrug-resistant hepatitis B virus strain in a chronic Turkish patient. |
Mutation
|
239 |
22312396 |
Prevalence and clinical significance of hepatitis B Basal core promoter and precore gene mutations in southern Iranian patients. |
Mutation
|
240 |
22313146 |
Reactivation of hepatitis B virus with mutated hepatitis B surface antigen in a liver transplant recipient receiving a graft from an antibody to hepatitis B surface antigen- and antibody to hepatitis B core antigen-positive donor. |
Mutation
|
241 |
22338219 |
[The mutation patterns of HBV P gene and genotyping in patients with lanivudine-resistant chronic hepatitis B]. |
Mutation
|
242 |
22340383 |
Characterization of hepatitis B virus genotypes/subgenotypes in 1,301 patients with chronic hepatitis B in North China. |
Mutation
|
243 |
22342116 |
Hepatitis B virus variant with the a194t substitution within reverse transcriptase before and under adefovir and tenofovir therapy. |
Mutation
|
244 |
22398037 |
The rtL229 substitutions in the reverse transcriptase region of hepatitis B virus (HBV) polymerase are potentially associated with lamivudine resistance as a compensatory mutation. |
Mutation
|
245 |
22442974 |
[Heterogeneity of hepatitis B virus and diagnostic potential of modern test systems for the detection of HBsAg]. |
Mutation
|
246 |
22453135 |
Long-term monitoring drug resistance by ultra-deep pyrosequencing in a chronic hepatitis B virus (HBV)-infected patient exposed to several unsuccessful therapy schemes. |
Mutation
|
247 |
22510826 |
Antiviral therapy against chronic hepatitis B in Brazil: high rates of lamivudine resistance mutations and correlation with HBV genotypes. |
Mutation
|
248 |
22523569 |
Dynamics of hepatitis B virus quasispecies in association with nucleos(t)ide analogue treatment determined by ultra-deep sequencing. |
Mutation
|
249 |
22579480 |
HBV genotypes prevalence, precore and basal core mutants in Morocco. |
Mutation
|
250 |
22585719 |
Factors influencing inadequate or suboptimal response to adefovir with or without genotypic resistance. |
Mutation
|
251 |
22666402 |
Ultra-deep pyrosequencing detects conserved genomic sites and quantifies linkage of drug-resistant amino acid changes in the hepatitis B virus genome. |
Mutation
|
252 |
22686039 |
[Analysis of the complete hepatitis B virus genomes in a patient for repeated seroconversion to anti-HBe antibody due to co-infection with two virus clones]. |
Mutation
|
253 |
22711345 |
Molecular analysis of hepatitis B virus associated with vaccine failure in infants and mothers: a case-control study in Thailand. |
Mutation
|
254 |
22720023 |
Hepatitis B virus gene mutations in liver diseases: a report from New Delhi. |
Mutation
|
255 |
22728692 |
Lamivudine plus adefovir or telbivudine plus adefovir for chronic hepatitis B patients with suboptimal response to adefovir. |
Mutation
|
256 |
22729192 |
YMDD motif mutations in chronic hepatitis B antiviral treatment naïve patients: a multi-center study. |
Mutation
|
257 |
22767306 |
Evaluation of a "home-made" method to determine viral genotype and characterize mutations conferring drug resistance in chronic hepatitis B patients. |
Mutation
|
258 |
22905181 |
Variability in the precore and core promoter regions of HBV strains in Morocco: characterization and impact on liver disease progression. |
Mutation
|
259 |
22919746 |
[Hepatitis B virus (HBV) mutation in enhancer I (HBV Enh I)/X-promoter and the relationship between chronic HBV-related disease spectrum]. |
Mutation
|
260 |
22941290 |
High prevalence of the B2+C2 subgenotype mixture in patients with chronic hepatitis B in Eastern China. |
Mutation
|
261 |
22960603 |
Hepatitis B virus basal core promoter mutations A1762T/G1764A are associated with genotype C and a low serum HBsAg level in chronically-infected HBeAg-positive Chinese patients. |
Mutation
|
262 |
22997074 |
Frequency and clinical significance of core promoter and precore region mutations in Tunisian patients infected chronically with hepatitis B. |
Mutation
|
263 |
23026293 |
Genotype-specific mutations in the polymerase gene of hepatitis B virus potentially associated with resistance to oral antiviral therapy. |
Mutation
|
264 |
23112104 |
Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion. |
Mutation
|
265 |
23113154 |
Identification of Hepatitis B Virus Surface Antigen (HBsAg) Genotypes and Variations in Chronic Carriers from Isfahan Province, Iran. |
Mutation
|
266 |
23146520 |
Hepatitis B reactivation in a renal transplant patient due to a surface antigen mutant strain: a case report. |
Mutation
|
267 |
23265059 |
[The panels of serums, containing various subtypes and mutant forms of HBsAg, to evaluate the diagnostics sensitivity of kits oa reagents detecting HBsAg]. |
Mutation
|
268 |
23322992 |
Long-term treatment outcomes of clevudine in antiviral-naive patients with chronic hepatitis B. |
Mutation
|
269 |
23355917 |
Efficacy of 3 years of adefovir monotherapy in chronic hepatitis B patients with lamivudine resistance. |
Mutation
|
270 |
23423477 |
Impact of rtI233V mutation in hepatitis B virus polymerase protein and adefovir efficacy: Homology modeling and molecular docking studies. |
Mutation
|
271 |
23458523 |
Efficacy and safety of telbivudine plus adefovir dipivoxil combination therapy and entecavir monotherapy for HBeAg-positive chronic hepatitis B patients with resistance to adefovir dipivoxil. |
Mutation
|
272 |
23485939 |
Virological response and antiviral resistance mutations in chronic hepatitis B subjects experiencing entecavir therapy: an Indian subcontinent perspective. |
Mutation
|
273 |
23596461 |
Drug-related mutational patterns in hepatitis B virus (HBV) reverse transcriptase proteins from Iranian treatment-naïve chronic HBV patients. |
Mutation
|
274 |
23599717 |
Correlation between viral load of HBV in chronic hepatitis B patients and precore and Basal core promoter mutations. |
Mutation
|
275 |
23602529 |
[Low prevalence of hepatitis B virus primary drug resistance in Southern Spain]. |
Mutation
|
276 |
23627028 |
[Mutation analysis of the HBV reverse transcriptase in nucleos(t)ide-treated patients with chronic HBV infection]. |
Mutation
|
277 |
23678186 |
The L60V variation in hepatitis B virus core protein elicits new epitope-specific cytotoxic T lymphocytes and enhances viral replication. |
Mutation
|
278 |
23710315 |
Quasispecies and pre-existing drug-resistant mutations of hepatitis B virus in patients with chronic hepatitis B. |
Mutation
|
279 |
23805155 |
Virological Response and Muscular Adverse Events during Long-Term Clevudine Therapy in Chronic Hepatitis B Patients. |
Mutation
|
280 |
23805180 |
Occult and Overt HBV Co-Infections Independently Predict Postoperative Prognosis in HCV-Associated Hepatocellular Carcinoma. |
Mutation
|
281 |
23852705 |
A complete genomic analysis of hepatitis B virus isolated from 516 Chinese patients with different clinical manifestations. |
Mutation
|
282 |
23871771 |
Positive selection signals of hepatitis B virus and their association with disease stages and viral genotypes. |
Mutation
|
283 |
23918533 |
Hepatitis B virus reverse transcriptase mutations in treatment Naïve chronic hepatitis B patients. |
Mutation
|
284 |
23968804 |
Dynamics of hepatitis B virus resistance substitutions correlates with virological response in lamivudine-refractory patients with entecavir rescue monotherapy. |
Mutation
|
285 |
23971933 |
[HBV vaccine escape mutations in a chronic hepatitis B patient treated with nucleos(t)ide analogues]. |
Mutation
|
286 |
24006435 |
HLA-DP polymorphisms affect the outcomes of chronic hepatitis B virus infections, possibly through interacting with viral mutations. |
Mutation
|
287 |
24009186 |
Unique surface gene variants of hepatitis B virus isolated from patients in the Philippines. |
Mutation
|
288 |
24021712 |
Hepatitis B virus in the State of Alagoas, Brazil: genotypes characterization and mutations of the precore and basal core promoter regions. |
Mutation
|
289 |
24064642 |
Mutation analysis of hepatitis B virus reverse transcriptase region among untreated chronically infected patients in Ahvaz city (South-West of Iran). |
Mutation
|
290 |
24160943 |
Profile of hepatitis B virus resistance mutations against nucleoside/nucleotide analogue treatment in Chinese patients with chronic hepatitis B. |
Mutation
|
291 |
24175847 |
Prevelance of common YMDD motif mutations in long term treated chronic HBV infections in a Turkish population. |
Mutation
|
292 |
24187552 |
The Possible Role of TLR2 in Chronic Hepatitis B Patients with Precore Mutation. |
Mutation
|
293 |
24237431 |
[Investigation of baseline antiviral resistance in treatment-naive chronic hepatitis B cases]. |
Mutation
|
294 |
24316031 |
Amino acid similarities and divergences in the small surface proteins of genotype C hepatitis B viruses between nucleos(t)ide analogue-naïve and lamivudine-treated patients with chronic hepatitis B. |
Mutation
|
295 |
24348637 |
Substitution rtq267h of hepatitis B virus increases the weight of replication and Lamivudine resistance. |
Mutation
|
296 |
24368224 |
Randomized comparison of tenofovir disoproxil fumarate vs emtricitabine and tenofovir disoproxil fumarate in patients with lamivudine-resistant chronic hepatitis B. |
Mutation
|
297 |
24399391 |
Antiviral efficacy of adefovir dipivoxil in the treatment of chronic hepatitis B subjects from Indian subcontinent. |
Mutation
|
298 |
24406435 |
Clinical significance of hepatitis B virus precore and core promoter variants in Korean patients with chronic hepatitis B. |
Mutation
|
299 |
24497877 |
Drug-resistance associated mutations in polymerase (p) gene of hepatitis B virus isolated from malaysian HBV carriers. |
Mutation
|
300 |
24589944 |
Lamivudine and Adefovir Motif Variants Detected in chronic Hepatıtıs B patients. |
Mutation
|
301 |
24630522 |
Analysis of potential antiviral resistance mutation profiles within the HBV reverse transcriptase in untreated chronic hepatitis B patients using an ultra-deep pyrosequencing method. |
Mutation
|
302 |
24637457 |
Mutation profiling of the hepatitis B virus strains circulating in North Indian population. |
Mutation
|
303 |
24696492 |
The impact of the hepatitis B virus polymerase rtA181T mutation on replication and drug resistance is potentially affected by overlapping changes in surface gene. |
Mutation
|
304 |
24790911 |
Analysis of reverse transcriptase gene mutations in the hepatitis B virus at a university hospital in Korea. |
Mutation
|
305 |
24836314 |
Viral evolutionary changes during tenofovir treatment in a chronic hepatitis B patient with sequential nucleos(t)ide therapy. |
Mutation
|
306 |
24992206 |
Investigation into drug-resistant mutations of HBV from 845 nucleoside/nucleotide analogue-naive Chinese patients with chronic HBV infection. |
Mutation
|
307 |
25028473 |
Impact of the rtI187V polymerase substitution of hepatitis B virus on viral replication and antiviral drug susceptibility. |
Mutation
|
308 |
25061278 |
Virologic breakthrough in a patient with chronic hepatitis B by combination treatment with tenofovir disoproxil fumarate and entecavir. |
Mutation
|
309 |
25170961 |
Correlation between the promoter basal core and precore mutations and HBsAg quantification in French blood donors infected with hepatitis B virus. |
Mutation
|
310 |
25208639 |
Performance of LigAmp assay for sensitive detection of drug-resistant hepatitis B virus minor variants in comparison with standard nucleotide sequencing. |
Mutation
|
311 |
25244642 |
Hepatitis B virus depicts a high degree of conservation during the immune-tolerant phase in familiarly transmitted chronic hepatitis B infection: deep-sequencing and phylogenetic analysis. |
Mutation
|
312 |
25287170 |
Long-term outcomes and dynamics of mutants associated with lamivudine-adefovir rescue therapy in patients with lamivudine-resistant chronic hepatitis B. |
Mutation
|
313 |
25303802 |
Different mechanism of selection of adefovir-resistant mutant viruses during adefovir monotherapy in patients with lamivudine-resistant chronic hepatitis B. |
Mutation
|
314 |
25318660 |
Incidence of natural resistance mutations in naïve chronic hepatitis B patients: a systematic review and meta-analysis. |
Mutation
|
315 |
25374716 |
Death from Liver Failure despite Lamivudine Prophylaxis during R-CHOP Chemotherapy due to Rapid Emergence M204 Mutations. |
Mutation
|
316 |
25382636 |
A deep-sequencing method detects drug-resistant mutations in the hepatitis B virus in Indonesians. |
Mutation
|
317 |
25452041 |
Specific mutations in the C-terminus domain of HBV surface antigen significantly correlate with low level of serum HBV-DNA in patients with chronic HBV infection. |
Mutation
|
318 |
25477976 |
Hepatitis B virus core promoter mutations in patients with chronic hepatitis B and hepatocellular carcinoma in bucharest, romania. |
Mutation
|
319 |
25626648 |
Hepatitis B virus genotypes and mutations in the basal core promoter and pre-core/core in chronically infected patients in southern Brazil: a cross-sectional study of HBV genotypes and mutations in chronic carriers. |
Mutation
|
320 |
25742145 |
Clinical course of chronic hepatitis B patients receiving nucleos(t)ide analogues after virological breakthrough during monotherapy with lamivudine. |
Mutation
|
321 |
25788956 |
Association of Mutations in the Basal Core Promoter and Pre-core Regions of the Hepatitis B Viral Genome and Longitudinal Changes in HBV Level in HBeAg Negative Individuals: Results From a Cohort Study in Northern Iran. |
Mutation
|
322 |
25817219 |
Characterization of novel entecavir resistance mutations. |
Mutation
|
323 |
25822176 |
Lower mutation frequency of BCP/precore regions in e antigen-negative chronic HBV-infected children instead of adults patients. |
Mutation
|
324 |
25825644 |
Correlation Between Hepatitis B G1896A Precore Mutations and HBeAg in Chronic HBV Patients. |
Mutation
|
325 |
25982306 |
Microarray-based genotyping and detection of drug-resistant HBV mutations from 620 Chinese patients with chronic HBV infection. |
Mutation
|
326 |
25989376 |
Impact of HBV genotypes A and D genetic variability on infection evolution. |
Mutation
|
327 |
25997324 |
[The drug resistance mutation detection and relevant factors analysis of HBV P region in chronic hepatitis B patients in Weifang City, Shandong Province]. |
Mutation
|
328 |
26045705 |
Efficacy of tenofovir disoproxil fumarate therapy in nucleoside-analogue naive Iranian patients treated for chronic hepatitis B. |
Mutation
|
329 |
26063382 |
Associations between hepatitis B virus basal core promoter/pre-core region mutations and the risk of acute-on-chronic liver failure: a meta-analysis. |
Mutation
|
330 |
26164128 |
Comparison of entecavir monotherapy and de novo lamivudine and adefovir combination therapy in HBeAg-positive chronic hepatitis B with high viral load: 48-week result. |
Mutation
|
331 |
26194746 |
Outcomes including liver histology after liver transplantation for chronic hepatitis B using oral antiviral therapy alone. |
Mutation
|
332 |
26201521 |
Naturally occurring core immune-escape and carboxy-terminal mutations\truncations in patients with e antigen negative chronic hepatitis B. |
Mutation
|
333 |
26202027 |
HBsAg, HBeAg and HBV DNA level changes and precore/basal core promoter mutations in the natural history of chronic hepatitis B in Indonesian patients. |
Mutation
|
334 |
26309637 |
Detection and analysis of resistance mutations of hepatitis B virus. |
Mutation
|
335 |
26313279 |
[Characterization of basal core promoter/precore gene mutations in chronically infected patients with hepatitis B virus genotype D in Mersin Province, Turkey]. |
Mutation
|
336 |
26382925 |
Resistant mutations and quasispecies complexity of hepatitis B virus during telbivudine treatment. |
Mutation
|
337 |
26389515 |
Predictors of hepatitis B e antigen-negative hepatitis in chronic hepatitis B virus-infected patients from childhood to adulthood. |
Mutation
|
338 |
26505028 |
A Nanoscale Mutation-Sensitive On/Off Switch Based Assays for the Detection of Hepatitis B Virus Lamivudine-Resistant Mutations. |
Mutation
|
339 |
26515673 |
Effect of tenofovir disoproxil fumarate on drug-resistant HBV clones. |
Mutation
|
340 |
26524917 |
[Variability of Reverse Transcriptase Gene and S Gene in Lamivudine-treated Chronic Hepatitis B Patients]. |
Mutation
|
341 |
26571304 |
Chronic hepatitis B in pregnant women: is hepatitis B surface antigen quantification useful for viral load prediction? |
Mutation
|
342 |
26571502 |
Virological Characteristics of Acute Hepatitis B in Eastern India: Critical Differences with Chronic Infection. |
Mutation
|
343 |
26577140 |
Hepatitis B virus basal core promoter/precore mutants and association with liver cirrhosis in children with chronic hepatitis B virus infection. |
Mutation
|
344 |
26587040 |
G1896A Precore Mutation and Association With HBeAg Status, Genotype and Clinical Status in Patients With Chronic Hepatitis B. |
Mutation
|
345 |
26613893 |
Mutations in the S gene and in the overlapping reverse transcriptase region in chronic hepatitis B Chinese patients with coexistence of HBsAg and anti-HBs. |
Mutation
|
346 |
26647737 |
Deep sequencing of hepatitis B virus basal core promoter and precore mutants in HBeAg-positive chronic hepatitis B patients. |
Mutation
|
347 |
26727850 |
GENOMIC ANALYSIS OF HEPATITIS B VIRUS STRAINS INFECTING ROMANIAN PATIENTS. |
Mutation
|
348 |
26876337 |
Prevalence of mutations in HBV DNA polymerase gene associated with nucleos(t)ide resistance in treatment-naive patients with Chronic Hepatitis B in Central China. |
Mutation
|
349 |
26889227 |
Evolution of entecavir-resistant hepatitis B virus during entecavir and adefovir dipivoxil combination therapy. |
Mutation
|
350 |
26901602 |
Investigation by the Method of INNO-LiPA of Primary Resistance to Lamivudine in Patients with Chronic Hepatitis B Who Have Not Used Antiviral Therapy. |
Mutation
|
351 |
26984835 |
Association between hepatitis B virus basal core promoter/precore region mutations and the risk of hepatitis B-related acute-on-chronic liver failure in the Chinese population: an updated meta-analysis. |
Mutation
|
352 |
26992056 |
Different precore/core mutations of hepatitis B interact with, limit, or favor liver fibrosis severity. |
Mutation
|
353 |
27006281 |
Higher detection rates of amino acid substitutions in HBV reverse transcriptase/surface protein overlapping sequence is correlated with lower serum HBV DNA and HBsAg levels in HBeAg-positive chronic hepatitis B patients with subgenotype B2. |
Mutation
|
354 |
27031988 |
Functional analysis of 'a' determinant mutations associated with occult HBV in HIV-positive South Africans. |
Mutation
|
355 |
27055927 |
Prevalence of mutations within major hydrophilic region of hepatitis B virus and their correlation with genotypes among chronically infected patients in Egypt. |
Mutation
|
356 |
27386641 |
[Effect of Telbivudine Tablet Combined Jianpi Bushen Recipe on HBV Specific Cytotoxic T Lymphocyte and HBeAg Seroconversion in Patients with HBeAg Positive Chronic Hepatitis B]. |
Mutation
|
357 |
27446286 |
Association between clinical features and YMDD mutations in patients with chronic hepatitis B following lamivudine therapy. |
Mutation
|
358 |
27504160 |
Mutational analysis of reverse transcriptase and surface proteins of patients with partial virological response during mono and combination antiviral therapies in genotype D chronic hepatitis B. |
Mutation
|
359 |
27583985 |
Small surface antigen variants of HBV associated with responses to telbivudine treatment in chronic hepatitis B patients. |
Mutation
|
360 |
27624502 |
Hepatitis B virus infection in children of HBV-related chronic liver disease patients: a study of intra-familial HBV transmission. |
Mutation
|
361 |
27651827 |
Molecular characterization of hepatitis B virus among chronic hepatitis B patients from Pointe Noire, Republic of Congo. |
Mutation
|
362 |
27694733 |
Monitoring of genotypic resistance profile in chronic hepatitis B patients receiving nucleos(t)ide analogues in Huzhou, China. |
Mutation
|
363 |
27787680 |
Identification of a new hepatitis B virus recombinant D2/D3 in the city of São Paulo, Brazil. |
Mutation
|
364 |
27812178 |
Evaluation of the G145R Mutant of the Hepatitis B Virus as a Minor Strain in Mother-to-Child Transmission. |
Mutation
|
365 |
27824315 |
Association study between mannose-binding lectin haplotypes and X gene mutation of hepatitis B virus from treatment naïve patients. |
Mutation
|
366 |
27894395 |
Relationship between hepatitis B virus reverse transcriptase 181 mutation and S gene mutation in hepatitis B virus chronically infected patients. |
Mutation
|
367 |
27998820 |
Core I97L mutation in conjunction with P79Q is associated with persistent low HBV DNA and HBs antigen clearance in patients with chronic hepatitis B. |
Mutation
|
368 |
28088502 |
The nucleotide changes within HBV core promoter/precore during the first 12weeks of nucleos(t)ide treatment might be associated with a better virological response. |
Mutation
|
369 |
28124958 |
[Atypical serological profiles in hepatitis B infections: investigation of S gene mutations in cases with concurrently positive for HBsAg and anti-HBs]. |
Mutation
|
370 |
28139541 |
Comparative evaluation of long-term monotherapies & combination therapies in patients with chronic hepatitis B: A pilot study. |
Mutation
|
371 |
28152517 |
Novel HBsAg mutations correlate with hepatocellular carcinoma, hamper HBsAg secretion and promote cell proliferation in vitro. |
Mutation
|
372 |
28198078 |
Mutation in the S gene of hepatitis B virus and anti-HBs subtype-nonspecificity contributed to the co-existence of HBsAg and anti-HBs in patients with chronic hepatitis B virus infection. |
Mutation
|
373 |
28236303 |
Characterization of hepatitis B virus (HBV) preS/S gene mutations in blood donors with occult HBV infection in the Baoji area of North China. |
Mutation
|
374 |
28300730 |
The enrichment of HBV immune-escape mutations during nucleoside/nucleotide analogue therapy. |
Mutation
|
375 |
28303969 |
HBV quasispecies composition in Lamivudine-failed chronic hepatitis B patients and its influence on virological response to Tenofovir-based rescue therapy. |
Mutation
|
376 |
28322924 |
Evolutionary trends of resistance mutational patterns of HBV reverse transcriptase over years (2002-2012) of different treatment regimens: The legacy of lamivudine/adefovir combination treatment. |
Mutation
|
377 |
28376852 |
Antiviral efficacy of entecavir for hepatitis B virus rtA181V/T mutants. |
Mutation
|
378 |
28381384 |
Novel HBV mutations and their value in predicting efficacy of conventional interferon. |
Mutation
|
379 |
28418295 |
Phenotypic and Genotypic Shifts in Hepatitis B Virus in Treatment-Naive Patients, Taiwan, 2008-2012. |
Mutation
|
380 |
28440785 |
Impacts of HBV rtH55R polymerase substitution on viral replication and rtM204I/V resistance to nucleoside/nucleotide antiviral drugs. |
Mutation
|
381 |
28445403 |
Detection of Hepatitis B Virus M204I Mutation by Quantum Dot-Labeled DNA Probe. |
Mutation
|
382 |
28500726 |
Mutations associated with drug resistance and prevalence of vaccine escape mutations in patients with chronic hepatitis B infection. |
Mutation
|
383 |
28582431 |
Hepatitis B genotypes and surface antigen mutants present in Pakistani blood donors. |
Mutation
|
384 |
28600703 |
Prevalence of S gene mutations within the major hydrophilic region of hepatitis B virus in patients in Dongguan, southern China. |
Mutation
|
385 |
28740410 |
Genotyping of HBV and tracking of resistance mutations in treatment-naïve patients with chronic hepatitis B. |
Mutation
|
386 |
28751727 |
Temporal trend of hepatitis B surface mutations in the post-immunization period: 9 years of surveillance (2005-2013) in eastern China. |
Mutation
|
387 |
28859616 |
Molecular characterization of hepatitis B virus in Vietnam. |
Mutation
|
388 |
28870025 |
Clinical characteristics of patients with chronic hepatitis B who developed genotypic resistance to entecavir: Real-life experience. |
Mutation
|
389 |
28902288 |
Basal core promoter and precore mutations among hepatitis B virus circulating in Brazil and its association with severe forms of hepatic diseases. |
Mutation
|
390 |
29248936 |
Patients with Coexistence of Circulating Hepatitis B Surface Antigen and Its Antibody May Have a Strong Predisposition to Virus Reactivation During Immunosuppressive Therapy: A Hypothesis. |
Mutation
|
391 |
29393485 |
Early changes in quasispecies variant after antiviral therapy for chronic hepatitis B. |
Mutation
|
392 |
29596494 |
High rates of chronic HBV genotype E infection in a group of migrants in Italy from West Africa: Virological characteristics associated with poor immune clearance. |
Mutation
|
393 |
29663445 |
Mutations within the major hydrophilic region (MHR) of Hepatitis B virus from individuals with simultaneous HBsAg and anti-HBs in Guangzhou, Southern China. |
Mutation
|
394 |
29739114 |
Mutations in Core Gene Region of Hepatitis B Virus in Patients with Chronic Hepatitis B. |
Mutation
|
395 |
29859062 |
Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe. |
Mutation
|
396 |
30095435 |
Association of characteristics of HBV quasispecies with hepatitis B surface antigen seroconversion after pegylated interferon-α-2a treatment in child patients. |
Mutation
|
397 |
30285571 |
Predictors of Therapeutic Outcome to Nucleotide Reverse Transcriptase Inhibitor in Hepatitis B Patients. |
Mutation
|
398 |
30505167 |
Hepatitis B virus precore G1896A mutation in chronic liver disease patients with HBeAg negative serology from North India. |
Mutation
|
399 |
30586543 |
Novel fluoronucleoside analog NCC inhibits lamivudine-resistant hepatitis B virus in a hepatocyte model. |
Mutation
|
400 |
30669266 |
Naturally Occurring Mutations within HBV Surface Promoter II Sequences Affect Transcription Activity, HBsAg and HBV DNA Levels in HBeAg-Positive Chronic Hepatitis B Patients. |
Mutation
|
401 |
30794889 |
Identification of a quadruple mutation that confers tenofovir resistance in chronic hepatitis B patients. |
Mutation
|
402 |
30835025 |
Pre-S/Surface and Core Promoter/Precore Mutations in Chronic Hepatitis B Patients with Severe Acute Exacerbation. |
Mutation
|
403 |
30906435 |
Viral quasispecies of hepatitis B virus in patients with YMDD mutation and lamivudine resistance may not predict the efficacy of lamivudine/adefovir rescue therapy. |
Mutation
|
404 |
31130119 |
[HBV pol/S gene mutations in chronic hepatitis B patients receiving nucleoside/nucleotide analogues treatment]. |
Mutation
|
405 |
31130120 |
[Determination of reverse transcriptase inhibitor nucleoside analogue resistance profile in pretreatment phase of patients with viral hepatitis B]. |
Mutation
|
406 |
31179360 |
Hepatitis B virus reverse transcriptase polymorphisms between treated and treatment-naïve chronically infected patients. |
Mutation
|
407 |
31189581 |
Characterization and Clinical Significance of Natural Variability in Hepatitis B Virus Reverse Transcriptase in Treatment-Naive Chinese Patients by Sanger Sequencing and Next-Generation Sequencing. |
Mutation
|
408 |
31308922 |
Nucleotide Substitutions in Hepatitis B Viruses Derived from Chronic HBV Patients. |
Mutation
|
409 |
31324819 |
Large-scale viral genome analysis identifies novel clinical associations between hepatitis B virus and chronically infected patients. |
Mutation
|
410 |
31341154 |
Association Between HBx Variations and Development of Severe Liver Disease Among Indonesian Patients. |
Mutation
|
411 |
31359359 |
Next generation sequencing identifies baseline viral mutants associated with treatment response to pegylated interferon in HBeAg-positive chronic hepatitis B. |
Mutation
|
412 |
31398372 |
Investigation of hepatitis B virus (HBV) rtS78T/sC69* mutation in a large cohort of chronic HBV-infected patients with nucleoside/nucleotide analogue treatment. |
Mutation
|
413 |
31442597 |
The modulation of HBsAg level by sI126T is affected by additional amino acid substitutions in the S region of HBV. |
Mutation
|
414 |
31498528 |
Entecavir resistance mutations rtL180M/T184L/M204V combined with rtA200V lead to tenofovir resistance. |
Mutation
|
415 |
31543688 |
Tenofovir is a more suitable treatment than entecavir for chronic hepatitis B patients carrying naturally occurring rtM204I mutations. |
Mutation
|
416 |
31565220 |
Association between host TNF-α, TGF-β1, p53 polymorphisms, HBV X gene mutation, HBV viral load and the progression of HBV-associated chronic liver disease in Indonesian patients. |
Mutation
|
417 |
31624004 |
Characteristics of amino acid substitutions within the "a" determinant region of hepatitis B virus in chronically infected patients with coexisting HBsAg and anti-HBs. |
Mutation
|
418 |
31731368 |
Compare with safety and efficacy of entecavir and adefovir dipivoxil combination therapy and tenofovir disoproxil fumarate monotherapy for chronic hepatitis B patient with adefovir-resistant. |
Mutation
|
419 |
32155009 |
[The prevalence clinically significant virus mutations among patients with chronic viral hepatitis B.] |
Mutation
|
420 |
32216026 |
Entecavir-resistant hepatitis B virus decreases surface antigenicity: A full genome and functional characterization. |
Mutation
|
421 |
32312174 |
Key mutations in the C-terminus of the HBV surface glycoprotein correlate with lower HBsAg levels in vivo, hinder HBsAg secretion in vitro and reduce HBsAg structural stability in the setting of HBeAg-negative chronic HBV genotype-D infection. |
Mutation
|
422 |
32466635 |
Low-level viremia and cirrhotic complications in patients with chronic hepatitis B according to adherence to entecavir. |
Mutation
|
423 |
32523313 |
Conservation and variability of hepatitis B core at different chronic hepatitis stages. |
Mutation
|
424 |
32545313 |
Impact of Lamivudine-Based Antiretroviral Treatment on Hepatitis B Viremia in HIV-Coinfected South Africans. |
Mutation
|
425 |
32568442 |
The genetic polymorphism down-regulating HLA-DRB1 enhancer activity facilitates HBV persistence, evolution and hepatocarcinogenesis in the Chinese Han population. |
Mutation
|
426 |
32569703 |
Hepatitis B virus mutation pattern rtA181S+T184I+M204I may contribute to multidrug resistance in clinical practice: Analysis of a large cohort of Chinese patients. |
Mutation
|
427 |
32579776 |
Virology analysis of chronic hepatitis B virus-infected patients treated for 28 days with JNJ-56136379 monotherapy. |
Mutation
|
428 |
32663786 |
Evidence of tenofovir resistance in chronic hepatitis B virus (HBV) infection: An observational case series of South African adults. |
Mutation
|
429 |
32695898 |
In silico functional and structural characterization of hepatitis B virus PreS/S-gene in Iranian patients infected with chronic hepatitis B virus genotype D. |
Mutation
|
430 |
32708399 |
COLD-PCR Method for Early Detection of Antiviral Drug-Resistance Mutations in Treatment-Naive Children with Chronic Hepatitis B. |
Mutation
|
431 |
32765014 |
Prevalence of Potential Resistance Related Variants Among Chinese Chronic Hepatitis B Patients Not Receiving Nucleos(T)ide Analogues. |
Mutation
|
432 |
32840739 |
An antiviral drug-resistant mutant of hepatitis B virus with high replication capacity in association with a large in-frame deletion in the preS1 region of viral surface gene. |
Mutation
|
433 |
32860707 |
Impacts of the Percentage of Basal Core Promoter Mutation on the Progression of Liver Fibrosis After Hepatitis B e Antigen Seroconversion. |
Mutation
|
434 |
32894807 |
Characterization of Hepatitis B virus polymerase mutations A194T and CYEI and tenofovir disoproxil fumarate or tenofovir alafenamide resistance. |
Mutation
|
435 |
32911905 |
[Clinical significance and mutation characteristics in the core promoter/pre-C region of different HBV genotypes in children]. |
Mutation
|
436 |
32994690 |
Investigation of immune escape-associated mutations of hepatitis B virus in patients harboring hepatitis B virus drug-resistance mutations. |
Mutation
|
437 |
33124952 |
Mutational characterization of HBV reverse transcriptase gene and the genotype-phenotype correlation of antiviral resistance among Chinese chronic hepatitis B patients. |
Mutation
|
438 |
8952268 |
[Detection of hepatitis B virus by using polymerase chain reaction and nonradioactive DNA probes. II. Identification of mutations in the core gene by PCR-direct sequencing and ASO probe method]. |
Mutation
|
439 |
9011456 |
Pathogenesis of chronic liver disease in patients with chronic hepatitis B virus infection without serum HBeAg. |
Mutation
|
440 |
9593029 |
Identification of more than one mutation in the hepatitis B virus polymerase gene arising during prolonged lamivudine treatment. |
Mutation
|
441 |
9728561 |
Emergence of an S gene mutant during thymosin alpha1 therapy in a patient with chronic hepatitis B. |
Mutation
|
442 |
9751010 |
Incidence and clinical significance of hepatitis B virus precore gene translation initiation mutations in e antigen-negative patients. |
Mutation
|
443 |
9862871 |
Transient selection of a hepatitis B virus polymerase gene mutant associated with a decreased replication capacity and famciclovir resistance. |
Mutation
|
444 |
33462964 |
Virologic analysis of tenofovir resistance in a patient with chronic hepatitis B experiencing viral breakthrough during combination treatment with tenofovir disoproxil fumarate and entecavir. |
Mutation
|
445 |
33562603 |
Distinctive HBV Replication Capacity and Susceptibility to Tenofovir Induced by a Polymerase Point Mutation in Hepatoma Cell Lines and Primary Human Hepatocytes. |
Mutation
|
446 |
33571155 |
Multiple drug-resistant HBV mutation may contribute to poor response of adefovir + entecavir in entecavir-resistant patients. |
Mutation
|
447 |
33603102 |
Sophisticated viral quasispecies with a genotype-related pattern of mutations in the hepatitis B X gene of HBeAg-ve chronically infected patients. |
Mutation
|
448 |
33671832 |
Predominance of HBV Genotype B and HDV Genotype 1 in Vietnamese Patients with Chronic Hepatitis. |
Mutation
|
449 |
33708042 |
Hepatitis B virus precore/core region mutations and genotypes among hepatitis B virus chronic carriers in South-Eastern, Nigeria. |
Mutation
|
450 |
33758517 |
The Occurrence of rtA194T Mutant After Long-Term Lamivudine Monotherapy Remains Sensitive to Tenofovir Disoproxil Fumarate: A Case Report. |
Mutation
|
451 |
33791326 |
Tenofovir Disoproxil Fumarate Is Superior to Entecavir in Reducing Hepatitis B Surface Antigen for Chronic Hepatitis B in China: 2-Year Comprehensive Comparative Result of a Matched Comparative Study. |
Mutation
|
452 |
33836203 |
Natural variability in surface antigen and reverse transcriptase domain of hepatitis B virus in treatment-naïve chronic HBV-infected Egyptian patients. |
Mutation
|
453 |
33857724 |
LCR based quick detection of hotspot G1896A mutation in patients with different spectrum of hepatitis B. |
Mutation
|
454 |
33959934 |
Spontaneous reactivation of hepatitis B virus with a frameshift mutation in the precore region in an elderly hepatitis B virus carrier with lifestyle-related diseases. |
Mutation
|
455 |
33986897 |
High Prevalence of Preexisting HBV Polymerase Mutations in Pregnant Women Does Not Limit the Antiviral Therapy Efficacy. |
Mutation
|